U.S. regulators on Friday approved the first drug developed specifically to reduce excessive sweating, a common condition that can cause people anxiety and affect their social lives.
Stories Related to Fda Oks First Drug Made To Reduce Excessive Sweating
www.wacotrib.com - RSS Results in news* of type article, Waco Tribune-Herald
Fri, 06/29/2018 - 8:38am
Sections: u.s.
Topics: Texas McLennan County Waco
RELATED ARTICLES
- New Texas law strengthens e-cigarette rules, relaxes weed possession punishment at schools
New law gives districts more flexibility with handling students found with marijuana on campus but requires punishment for students found with a vape. More - El Paso police lieutenant, sergeant arrested on sexual harassment allegations
Two El Paso police supervisors were arrested, accused of "disturbing incidents" of sexual harassment of female officers. More - Hundreds of new laws go into effect Friday in Texas. Here are a few you should know
The 774 bills going into effect Sept. 1 will touch nearly all aspects of daily life in Texas. From car registrations to hospital visits. More - Travis County judge rules HB 2127, the so-called 'Death Star' bill, is unconstitutional
The ruling from state District Judge Maya Guerra Gamble comes two days before the law was set to go into effect. The state is likely to appeal. More - Lower Valley home catches fire twice in 15 hours, arson investigation underway
El Paso fire marshals are conducting an arson investigation after a Lower Valley house caught fire twice in just over 15 hours. More
BING NEWS:
- FDA OKs First IL-15 Receptor Agonist for Early Bladder Cancer
A first-in-class interleukin (IL)-15 receptor agonist, the drug is specifically approved in combination with BCG for adults with BCG-unresponsive NMIBC with carcinoma in situ with or without ...
04/22/2024 - 12:59 pm | View Link - Basilea completes marathon quest with FDA approval to treat 3 types of infections
A year later, Basilea regained rights to Zevtera after J&J decided to move on from the drug. In 2014, the FDA sent another CRL, rejecting Zevtera in CABP and requesting a new phase 3 trial.
04/3/2024 - 9:45 pm | View Link - Amylyx pulls FDA-approved ALS drug after trial failure
Amylyx Pharmaceuticals is pulling its drug to treat amyotrophic lateral sclerosis (ALS) from the shelves after it failed in a confirmatory trial. The company has started the process of ...
04/3/2024 - 1:00 pm | View Link - FDA OKs Injectable Antibiotic for Three Different Uses
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved the injectable drug ceftobiprole medocaril sodium (Zevtera) to treat adults with Staphylococcus aureus ...
04/2/2024 - 12:59 pm | View Link - Otsuka’s digital treatment for depression cleared by FDA, as pharma tries to crack tricky market
The Food and Drug Administration has cleared Otsuka Pharmaceutical’s digital treatment for major depressive disorder, offering a new option for millions of people who struggle with the stubborn ...
03/31/2024 - 1:00 pm | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more